Cannabis does not treat HIV itself, but it has real evidence for two HIV-related symptoms: smoked cannabis relieved HIV nerve pain in two small placebo-controlled trials, and dronabinol (synthetic THC) is FDA-approved for AIDS-related appetite loss and weight loss. A short-term trial found cannabis did not raise viral load or harm CD4 counts, but long-term effects on HIV outcomes remain unproven.
People living with HIV were among the first patients to push for medical cannabis in the 1990s, when AIDS wasting and nerve pain were common and few treatments worked. Antiretroviral therapy (ART) has since changed HIV into a manageable chronic condition, but neuropathy, poor appetite, nausea, sleep problems and chronic inflammation still affect many people. This guide covers the clinical trials, the FDA-approved cannabinoid drugs, the research on inflammation, and the risks. For more topics, see our cannabis research hub.
Evidence at a Glance: Cannabis and HIV/AIDS
| Claim | Evidence level | Source |
|---|---|---|
| Dronabinol treats anorexia with weight loss in AIDS | FDA-approved indication | FDA |
| Cannabis or cannabinoids improve appetite and weight in HIV/AIDS | Limited | National Academies, 2017 |
| Smoked cannabis relieves HIV-associated neuropathic pain | Moderate for short-term use (two small RCTs) | Abrams 2007; Ellis 2009 |
| Cannabis reduces HIV/AIDS illness or death | Insufficient | Cochrane review, 2013 |
| Short-term cannabis use does not raise viral load or lower CD4 counts | Limited (one 21-day RCT) | Abrams 2003 |
| Cannabis affects immune status in people with HIV | Insufficient | National Academies, 2017 |
| Cannabis lowers chronic inflammation in people with HIV | Early (mostly observational and lab data) | Langat et al., 2025 review |
FDA-Approved Cannabinoid Drugs for AIDS
Dronabinol, a synthetic form of THC, is sold as Marinol (capsules) and Syndros (oral solution). The FDA has approved both for anorexia associated with weight loss in patients with AIDS, and for chemotherapy nausea that has not responded to other drugs. This is one of the few places where the FDA has formally accepted a cannabinoid as a treatment.
The approval dates from the era of AIDS wasting, and the evidence behind it is older and modest. The 2013 Cochrane review of cannabis in HIV/AIDS found seven short randomized trials, lasting 21 to 84 days. The largest dronabinol study, run before modern ART, showed patients were about twice as likely to gain 2 kg or more, but the result was not statistically certain, and average weight gain was small. The reviewers concluded that evidence for efficacy and safety was “lacking” and that long-term data on people taking effective ART had yet to appear. The National Academies likewise rated the evidence for appetite and weight in HIV/AIDS as limited.
HIV Nerve Pain: The Strongest Clinical Evidence
HIV-associated sensory neuropathy causes burning, tingling or stabbing pain, usually in the feet, and responds poorly to many pain drugs. Two University of California trials tested smoked cannabis:
- UCSF, 2007. In a trial published in Neurology, 50 patients smoked cannabis (3.56% THC) or placebo cigarettes three times a day for five days. Daily pain fell by a median 34% with cannabis vs 17% with placebo. A 30% or greater pain reduction was reported by 52% of the cannabis group and 24% of the placebo group. No serious side effects were reported.
- UC San Diego, 2009. In a crossover trial in Neuropsychopharmacology, 28 patients whose pain had not responded to at least two other drug classes completed weeks of both cannabis (1% to 8% THC) and placebo. Pain relief was greater with cannabis, and 46% reached at least 30% relief vs 18% with placebo. Two participants had side effects that limited treatment.
These trials fit the broader finding of the National Academies that there is substantial evidence cannabis is effective for chronic pain in adults. They were small and lasted only days, and both used smoked cannabis under supervision, so they do not settle long-term benefit or the best form to use.
Does Cannabis Affect Viral Load or CD4 Counts?
Early concerns were that cannabis might weaken the immune system or interfere with HIV drugs that share liver pathways. A 2003 UCSF trial in the Annals of Internal Medicine tested this directly. Sixty-seven people with HIV, whose protease inhibitor drug levels were also tracked, were randomized to smoked cannabis, dronabinol or placebo three times daily for 21 days. Neither form of THC increased HIV viral load, and CD4 and CD8 counts and protease inhibitor levels were not harmed. The authors concluded that, over 21 days, cannabinoids “did not seem to be unsafe” on these measures.
Three weeks is a short window. The National Academies concluded there is no or insufficient evidence to support or refute a link between cannabis use and immune status in people with HIV.
Inflammation: A Newer Research Question
Even with a suppressed viral load, people with HIV tend to have persistent inflammation, which is linked to heart disease, cognitive problems and earlier death. Reviews by Ellis and colleagues (2021) and Langat and colleagues (2025) describe studies in which cannabis use was associated with lower levels of some inflammatory markers, less immune activation and changes in gut health. The 2025 review notes that effects on the hidden HIV reservoir, on ART adherence and on long-term outcomes are unknown and need rigorous trials with standardized products. This is a lead worth following, not a reason to use cannabis as an anti-inflammatory treatment.
Risks and Side Effects
- Drug interactions. THC and CBD are processed by liver enzymes (cytochrome P450) that also handle several antiretrovirals, as the 2003 trial authors noted. Ask your HIV clinician or pharmacist before combining them.
- Lung health. Long-term cannabis smoking is linked to worse respiratory symptoms and more bronchitis, according to the National Academies. Our guide to the healthiest ways to use cannabis compares options.
- Mental health and problem use. Frequent use is linked to a higher risk of psychosis and of cannabis use disorder. See our guide to marijuana addiction.
- Memory and attention. THC can worsen short-term memory, which matters for anyone who already has HIV-associated cognitive problems or needs to remember daily doses.
- Impaired driving. Cannabis use is linked to a higher risk of motor vehicle crashes.
Talk to Your Doctor
Your HIV care team should know about any cannabis or CBD use. Ask whether it could interact with your specific regimen, whether a prescription option such as dronabinol makes more sense for appetite, and what non-cannabis treatments exist for neuropathy. Never skip or delay ART because of cannabis; staying on treatment is what protects your immune system. If you live in Washington or Oregon, licensed stores sell tested products; see our Oregon dispensary directory and Oregon marijuana laws. For dosing basics, read our cannabis dosage guide.
Cannabis and HIV FAQ
Does marijuana help people with HIV?
It can help some symptoms. Small trials found smoked cannabis relieved HIV nerve pain, and dronabinol is FDA-approved for AIDS-related appetite and weight loss. Cannabis does not treat the virus.
Does cannabis lower CD4 counts or raise viral load?
In a 21-day randomized trial, neither smoked cannabis nor dronabinol raised viral load or lowered CD4 counts. Long-term effects have not been established.
Is dronabinol the same as medical marijuana?
No. Dronabinol is a synthetic version of THC, a single compound in a prescription capsule or liquid. Cannabis contains THC plus many other compounds in varying amounts.
Can cannabis interact with HIV medications?
Possibly. Cannabinoids share liver pathways with some antiretrovirals. A short trial found no harmful change in protease inhibitor levels, but you should ask your clinician or pharmacist about your specific drugs.
Does cannabis help HIV neuropathy?
Two placebo-controlled trials found that about half of patients smoking cannabis got at least 30% pain relief, compared with about one in five on placebo. The trials were small and lasted only days.
Can CBD reduce inflammation in HIV?
Researchers are studying it. Reviews describe lower inflammatory markers in some cannabis users with HIV, but there are no completed trials showing CBD improves health outcomes in HIV.
For adults 21+ in legal states. General information, not medical advice. Talk to a doctor before using cannabis for a health condition.